AMPA Receptor Antagonists Facilitate NEDD4-2-Mediated GRIA1 Ubiquitination by Regulating PP2B-ERK1/2-SGK1 Pathway in Chronic Epilepsy Rats
Open Access
- 23 August 2021
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 9 (8) , 1069
Abstract
The neural precursor cell expressed by developmentally downregulated gene 4-2 (NEDD4-2) is a ubiquitin E3 ligase that has a high affinity toward binding and ubiquitinating glutamate ionotropic receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type subunit 1 (GRIA1, also referred to GluR1 or GluA1). Since dysregulation of GRIA1 surface expression is relevant to the responsiveness to AMPA receptor (AMPAR) antagonists (perampanel and GYKI 52466) in chronic epilepsy rats, it is likely that NEDD4-2 may be involved in the pathogenesis of intractable epilepsy. However, the role of NEDD4-2-mediated GRIA1 ubiquitination in refractory seizures to AMPAR antagonists is still unknown. In the present study, both AMPAR antagonists recovered the impaired GRIA1 ubiquitination by regulating protein phosphatase 2B (PP2B)-extracellular signal-regulated kinase 1/2 (ERK1/2)-serum and glucocorticoid-regulated kinase 1 (SGK1)-NEDD4-2 signaling pathway in responders (whose seizure activities are responsive to AMPAR), but not non-responders (whose seizure activities were uncontrolled by AMPAR antagonists). In addition, cyclosporin A (CsA, a PP2B inhibitor) co-treatment improved the effects of AMPAR antagonists in non-responders, independent of AKT signaling pathway. Therefore, our findings suggest that dysregulation of PP2B-ERK1/2-SGK1-NEDD4-2-mediated GRIA1 ubiquitination may be responsible for refractory seizures and that this pathway may be a potential therapeutic target for improving the treatment of intractable epilepsy in response to AMPAR antagonists.Keywords
Funding Information
- National Research Foundation of Korea (NRF) (No. 2021R1A2C4002003, No. 2021R1A2B5B01001482)
This publication has 62 references indexed in Scilit:
- De novo mutations in epileptic encephalopathiesNature, 2013
- Neuronal Ubiquitin HomeostasisCell Biochemistry and Biophysics, 2013
- Protein Kinase C (PKC)-promoted Endocytosis of Glutamate Transporter GLT-1 Requires Ubiquitin Ligase Nedd4-2-dependent Ubiquitination but Not PhosphorylationJournal of Biological Chemistry, 2012
- Regulation of AMPA receptor trafficking and synaptic plasticityCurrent Opinion in Neurobiology, 2012
- Ubiquitin-dependent endocytosis, trafficking and turnover of neuronal membrane proteinsMolecular and Cellular Neuroscience, 2012
- Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2) Regulation by 14-3-3 Protein Binding at Canonical Serum and Glucocorticoid Kinase 1 (SGK1) Phosphorylation SitesJournal of Biological Chemistry, 2011
- Nedd4‐mediated AMPA receptor ubiquitination regulates receptor turnover and traffickingJournal of Neurochemistry, 2011
- Activity-Dependent Ubiquitination of GluA1 Mediates a Distinct AMPA Receptor Endocytosis and Sorting PathwayThe Journal of Neuroscience, 2010
- CaMKII Negatively Regulates Calcineurin–NFAT Signaling in Cardiac MyocytesCirculation Research, 2009
- Akt Mediates the Effect of Insulin on Epithelial Sodium Channels by Inhibiting Nedd4-2Journal of Biological Chemistry, 2007